Bronchiectasis Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Airway clearance techniques for bronchiectasis
Cochrane Systematic Review: Airway clearance techniques for bronchiectasis
- Visit
Lee AL, Burge A, Holland AE.
Lee AL, Burge A, Holland AE.
Objectives: Primary: to determine the effects of ACTs on the rate of acute exacerbations, incidence of hospitalisation and health-related quality of life in individuals with acute and stable bronchiectasis.Secondary: to determine whether a) ACTs are safe for individuals with acute and stable bronchiectasis and b) ACTs have beneficial effects on physiology and symptoms in individuals with acute and stable bronchiectasis.
Objectives: Primary: to determine the effects of ACTs on the rate of acute exacerbations, incidence of hospitalisation and health-related quality of life in individuals with acute and stable bronchiectasis.Secondary: to determine whether a) ACTs are safe for individuals with acute and stable bronchiectasis and b) ACTs have beneficial effects on physiology and symptoms in individuals with acute and stable bronchiectasis.
Cochrane Systematic Review: Anticholinergic therapy for bronchiectasis
Cochrane Systematic Review: Anticholinergic therapy for bronchiectasis
- Visit
Lasserson T, Holt K, Evans D, Greenstone M.
Lasserson T, Holt K, Evans D, Greenstone M.
Objectives: To determine the effect of anticholinergic therapy in acute exacerbations and stable bronchiectasis.
Objectives: To determine the effect of anticholinergic therapy in acute exacerbations and stable bronchiectasis.
Cochrane Systematic Review: Influenza vaccine for children and adults with bronchiectasis
Cochrane Systematic Review: Influenza vaccine for children and adults with bronchiectasis
- Visit
Chang CC, Morris PS, Chang AB.
Chang CC, Morris PS, Chang AB.
Objectives: To evaluate the effectiveness of influenza vaccine as routine management in children and adults with bronchiectasis in (a) reducing the severity and frequency of respiratory exacerbations and (b) pulmonary decline
Objectives: To evaluate the effectiveness of influenza vaccine as routine management in children and adults with bronchiectasis in (a) reducing the severity and frequency of respiratory exacerbations and (b) pulmonary decline
Cochrane Systematic Review: Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Review: Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis
- Visit
Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB.
Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB.
Objectives: To evaluate the efficacy of inhaled NSAIDs in the management of non-cystic fibrosis bronchiectasis in children and adults.
Objectives: To evaluate the efficacy of inhaled NSAIDs in the management of non-cystic fibrosis bronchiectasis in children and adults.
Cochrane Systematic Review: Inhaled steroids for bronchiectasis
Cochrane Systematic Review: Inhaled steroids for bronchiectasis
- Visit
Kapur N, Bell S, Kolbe J, Chang AB.
Kapur N, Bell S, Kolbe J, Chang AB.
Objectives: To evaluate the efficacy of inhaled corticosteroids (ICS) in children and adults with bronchiectasis (a) during stable bronchiectasis; and for reducing; (b) the severity and frequency of acute respiratory exacerbations and (c) long term pulmonary decline.
Objectives: To evaluate the efficacy of inhaled corticosteroids (ICS) in children and adults with bronchiectasis (a) during stable bronchiectasis; and for reducing; (b) the severity and frequency of acute respiratory exacerbations and (c) long term pulmonary decline.
Cochrane Systematic Review: Long-acting beta2-agonists for bronchiectasis
Cochrane Systematic Review: Long-acting beta2-agonists for bronchiectasis
- Visit
Sheikh A, Nolan D, Greenstone M.
Sheikh A, Nolan D, Greenstone M.
Objectives: To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
Objectives: To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
Cochrane Systematic Review: Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
Cochrane Systematic Review: Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
- Visit
Lasserson T, Holt K, Greenstone M.
Lasserson T, Holt K, Greenstone M.
Objectives: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
Objectives: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
Cochrane Systematic Review: Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Review: Oral non steroid anti-inflammatories for children and adults with bronchiectasis
- Visit
Kapur N, Chang AB.
Kapur N, Chang AB.
Objectives: To assess the role of non steroid anti inflammatory drugs (NSAIDs) on symptom control and natural history of the disease in children and adults with bronchiectasis.
Objectives: To assess the role of non steroid anti inflammatory drugs (NSAIDs) on symptom control and natural history of the disease in children and adults with bronchiectasis.
Cochrane Systematic Review: Short acting beta2-agonists for bronchiectasis
Cochrane Systematic Review: Short acting beta2-agonists for bronchiectasis
- Visit
Franco F, Sheikh A, Greenstone M.
Franco F, Sheikh A, Greenstone M.
Objectives: The present review examined the effectiveness of short acting beta-2 agonist therapy in bronchiectasis, as this is the most frequently used treatment for airflow obstruction in people with this condition.
Objectives: The present review examined the effectiveness of short acting beta-2 agonist therapy in bronchiectasis, as this is the most frequently used treatment for airflow obstruction in people with this condition.
Cochrane Systematic Review: Short courses of antibiotics for children and adults with bronchiectasis
Cochrane Systematic Review: Short courses of antibiotics for children and adults with bronchiectasis
- Visit
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IB, Chang AB.
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IB, Chang AB.
Objectives: To determine whether short courses of antibiotics (i.e. less than or equal to four weeks) for treatment of acute and stable state bronchiectasis, in adults and children, are efficacious when compared to placebo or usual care.
Objectives: To determine whether short courses of antibiotics (i.e. less than or equal to four weeks) for treatment of acute and stable state bronchiectasis, in adults and children, are efficacious when compared to placebo or usual care.
Cochrane Systematic Review: Airway clearance techniques for bronchiectasis
Cochrane Systematic Review: Airway clearance techniques for bronchiectasis
- Visit
Lee AL, Burge A, Holland AE.
Lee AL, Burge A, Holland AE.
Objectives: Primary: to determine the effects of ACTs on the rate of acute exacerbations, incidence of hospitalisation and health-related quality of life in individuals with acute and stable bronchiectasis.Secondary: to determine whether a) ACTs are safe for individuals with acute and stable bronchiectasis and b) ACTs have beneficial effects on physiology and symptoms in individuals with acute and stable bronchiectasis.
Objectives: Primary: to determine the effects of ACTs on the rate of acute exacerbations, incidence of hospitalisation and health-related quality of life in individuals with acute and stable bronchiectasis.Secondary: to determine whether a) ACTs are safe for individuals with acute and stable bronchiectasis and b) ACTs have beneficial effects on physiology and symptoms in individuals with acute and stable bronchiectasis.
Cochrane Systematic Review: Anticholinergic therapy for bronchiectasis
Cochrane Systematic Review: Anticholinergic therapy for bronchiectasis
- Visit
Lasserson T, Holt K, Evans D, Greenstone M.
Lasserson T, Holt K, Evans D, Greenstone M.
Objectives: To determine the effect of anticholinergic therapy in acute exacerbations and stable bronchiectasis.
Objectives: To determine the effect of anticholinergic therapy in acute exacerbations and stable bronchiectasis.
Cochrane Systematic Review: Influenza vaccine for children and adults with bronchiectasis
Cochrane Systematic Review: Influenza vaccine for children and adults with bronchiectasis
- Visit
Chang CC, Morris PS, Chang AB.
Chang CC, Morris PS, Chang AB.
Objectives: To evaluate the effectiveness of influenza vaccine as routine management in children and adults with bronchiectasis in (a) reducing the severity and frequency of respiratory exacerbations and (b) pulmonary decline
Objectives: To evaluate the effectiveness of influenza vaccine as routine management in children and adults with bronchiectasis in (a) reducing the severity and frequency of respiratory exacerbations and (b) pulmonary decline
Cochrane Systematic Review: Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Review: Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasis
- Visit
Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB.
Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB.
Objectives: To evaluate the efficacy of inhaled NSAIDs in the management of non-cystic fibrosis bronchiectasis in children and adults.
Objectives: To evaluate the efficacy of inhaled NSAIDs in the management of non-cystic fibrosis bronchiectasis in children and adults.
Cochrane Systematic Review: Inhaled steroids for bronchiectasis
Cochrane Systematic Review: Inhaled steroids for bronchiectasis
- Visit
Kapur N, Bell S, Kolbe J, Chang AB.
Kapur N, Bell S, Kolbe J, Chang AB.
Objectives: To evaluate the efficacy of inhaled corticosteroids (ICS) in children and adults with bronchiectasis (a) during stable bronchiectasis; and for reducing; (b) the severity and frequency of acute respiratory exacerbations and (c) long term pulmonary decline.
Objectives: To evaluate the efficacy of inhaled corticosteroids (ICS) in children and adults with bronchiectasis (a) during stable bronchiectasis; and for reducing; (b) the severity and frequency of acute respiratory exacerbations and (c) long term pulmonary decline.
Cochrane Systematic Review: Long-acting beta2-agonists for bronchiectasis
Cochrane Systematic Review: Long-acting beta2-agonists for bronchiectasis
- Visit
Sheikh A, Nolan D, Greenstone M.
Sheikh A, Nolan D, Greenstone M.
Objectives: To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
Objectives: To determine the effectiveness of long-acting bronchodilators in the management of bronchiectasis that is not due to cystic fibrosis.
Cochrane Systematic Review: Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
Cochrane Systematic Review: Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
- Visit
Lasserson T, Holt K, Greenstone M.
Lasserson T, Holt K, Greenstone M.
Objectives: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
Objectives: To determine the efficacy of oral corticosteroids in acute and stable bronchiectasis
Cochrane Systematic Review: Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Cochrane Systematic Review: Oral non steroid anti-inflammatories for children and adults with bronchiectasis
- Visit
Kapur N, Chang AB.
Kapur N, Chang AB.
Objectives: To assess the role of non steroid anti inflammatory drugs (NSAIDs) on symptom control and natural history of the disease in children and adults with bronchiectasis.
Objectives: To assess the role of non steroid anti inflammatory drugs (NSAIDs) on symptom control and natural history of the disease in children and adults with bronchiectasis.
Cochrane Systematic Review: Short acting beta2-agonists for bronchiectasis
Cochrane Systematic Review: Short acting beta2-agonists for bronchiectasis
- Visit
Franco F, Sheikh A, Greenstone M.
Franco F, Sheikh A, Greenstone M.
Objectives: The present review examined the effectiveness of short acting beta-2 agonist therapy in bronchiectasis, as this is the most frequently used treatment for airflow obstruction in people with this condition.
Objectives: The present review examined the effectiveness of short acting beta-2 agonist therapy in bronchiectasis, as this is the most frequently used treatment for airflow obstruction in people with this condition.
Cochrane Systematic Review: Short courses of antibiotics for children and adults with bronchiectasis
Cochrane Systematic Review: Short courses of antibiotics for children and adults with bronchiectasis
- Visit
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IB, Chang AB.
Wurzel D, Marchant JM, Yerkovich ST, Upham JW, Masters IB, Chang AB.
Objectives: To determine whether short courses of antibiotics (i.e. less than or equal to four weeks) for treatment of acute and stable state bronchiectasis, in adults and children, are efficacious when compared to placebo or usual care.
Objectives: To determine whether short courses of antibiotics (i.e. less than or equal to four weeks) for treatment of acute and stable state bronchiectasis, in adults and children, are efficacious when compared to placebo or usual care.
